CAMBRIDGE, MA / ACCESS Newswire / March 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Australian Therapeutic Goods Administration (TGA) has granted approval for mRESVIA® (mRNA-1345), ...

The S&P 500 and Nasdaq lost ground at midday as the Trump administration's reciprocal tariffs are set to kick in this week.

Australian medicines regulator, the Therapeutic Goods Administration (TGA), has granted approval for mRESVIA (mRNA-1345), an ...

Investing.com -- Moderna (NASDAQ: MRNA) shares dropped 13% pre-open on Monday as investors reacted to the weekend news that the U.S. Food and Drug Administration’s (FDA) top vaccine official, Dr.

Live Updates Live Coverage Updates appear automatically as they are published. Stocks Trim Losses 10:30 am The stock market ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...

The S&P 500 and the Nasdaq hit more than six-month lows on Monday as investors steered clear of risk-laden assets on worries ...

Stocks fell on Monday after the Wall Street Journal reported that President Donald Trump has pushed his team to be more ...

Stock futures edged lower on Monday due to trade war concerns and the upcoming 25% levy on non-US cars. President Trump has ...

The S&P 500 and the Nasdaq fell on Monday, with technology stocks leading declines, as investors steered clear of risk-laden ...

US stocks tumbled to their lowest levels in over six months as worries over new tariffs weighed on investor sentiment. With ...

Eastern time, the S&P 500 was down 0.8 per cent, the Dow Jones Industrial Average was down 0.3 per cent, and the Nasdaq ...